In 2023, the treatment success rate for patients treated for multidrug-resistant tuberculosis in India was 56%. From 2024 to 2028, forecasts indicate a gradual increase from 57% to 58%. The year-on-year percentage variation is minimal, indicating a 0% growth from 2024 to 2026 and a slight increase of less than 2% from 2027 onwards. The 5-year compound annual growth rate (CAGR) suggests a modest growth trend.

Future trends to watch for:

Technological advancements in treatment may improve success rates.
Government policy changes could impact the accessibility and effectiveness of treatment.
Increased global cooperation may lead to more effective strategies for combating drug-resistant strains.